1-185734841-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_031935.3(HMCN1):c.62C>T(p.Ala21Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000821 in 1,461,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A21A) has been classified as Likely benign.
Frequency
Consequence
NM_031935.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HMCN1 | NM_031935.3 | c.62C>T | p.Ala21Val | missense_variant | 1/107 | ENST00000271588.9 | |
HMCN1 | XM_011510038.4 | c.62C>T | p.Ala21Val | missense_variant | 1/106 | ||
HMCN1 | XM_024450118.2 | c.62C>T | p.Ala21Val | missense_variant | 1/67 | ||
HMCN1 | XM_011510041.4 | c.62C>T | p.Ala21Val | missense_variant | 1/61 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HMCN1 | ENST00000271588.9 | c.62C>T | p.Ala21Val | missense_variant | 1/107 | 1 | NM_031935.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251496Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135922
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461690Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727162
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2023 | The c.62C>T (p.A21V) alteration is located in exon 1 (coding exon 1) of the HMCN1 gene. This alteration results from a C to T substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at